Balance Sheet

v3.23.3

CONDENSED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 45,414	$ 24,459
Short-term investments	16,937	33,747
Accounts receivable, net	23,546	40,320
Inventories	6,112	9,118
Prepaid and other current assets	3,015	8,259
Total current assets	95,024	115,903
Property and equipment, net	190	857
Intangible asset, net	14,146	14,949
Operating lease right-of-use asset	1,008	1,930
Other assets	4,956	640
Total assets	115,324	134,279
Current liabilities:
Accounts payable	7,999	22,508
Accrued compensation	8,093	8,866
Accrued research and development	5,754	7,708
Revenue reserves and refund liability	14,543	12,145
Other accrued liabilities	5,030	6,485
Lease liabilities, current portion	673	1,133
Deferred revenue	1,355	1,369
Other long-term liabilities, current portion	4,826	4,997
Total current liabilities	48,273	65,211
Long-term portion of lease liabilities	466	972
Loans payable, net of discount	59,659	39,448
Other long-term liabilities	38,760	42,264
Total liabilities	147,158	147,895
Commitments
Stockholders' deficit:
Preferred stock
Common stock	175	174
Additional paid-in capital	1,376,293	1,368,822
Accumulated other comprehensive loss	(15)	(153)
Accumulated deficit	(1,408,287)	(1,382,459)
Total stockholders' deficit	(31,834)	(13,616)
Total liabilities and stockholders' deficit	$ 115,324	$ 134,279

- Definition

Represents the carrying value as of the balance sheet date of research and development costs that are incurred but not billed to the entity as of the end of the period. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

No definition available.

Source